T1	Disorder 0 8	Delirium
N1 	Reference T1 UMLS:C0011206	Delirium
T2	Pharmacological_substance 33 43	flecainide
N1000 	Reference T2 MeSH:D005424	flecainide
T3	Pharmacological_substance 119 129	paroxetine
N1001 	Reference T3 MeSH:D017374	paroxetine
T4	Pharmacological_substance 153 163	flecainide
N1002 	Reference T4 MeSH:D005424	flecainide
T5	Disorder 172 180	delirium
N2 	Reference T5 UMLS:C0011206	delirium
T6	Pharmacological_substance 237 247	paroxetine
N1003 	Reference T6 MeSH:D017374	paroxetine
T7	Disorder 332 341	confusion
N3 	Reference T7 UMLS:C0009676	confusion
N4 	Reference T7 UMLS:C0683369	confusion
T8	Disorder 346 354	paranoia
N5 	Reference T8 UMLS:C1456784	paranoia
T9	Pharmacological_substance 419 429	carvedilol
N1004 	Reference T9 MeSH:C043211	carvedilol
T11	Pharmacological_substance 449 457	warfarin
N1005 	Reference T11 MeSH:D014859	warfarin
T13	Pharmacological_substance 468 478	folic acid
N1006 	Reference T13 MeSH:D005492	folic acid
T15	Pharmacological_substance 489 502	levothyroxine
N1007 	Reference T15 MeSH:D013974	levothyroxine
T17	Pharmacological_substance 519 531	pantoprazole
N1008 	Reference T17 MeSH:C064276	pantoprazole
T19	Pharmacological_substance 543 553	paroxetine
N1009 	Reference T19 MeSH:D017374	paroxetine
T21	Pharmacological_substance 569 579	flecainide
N1010 	Reference T21 MeSH:D005424	flecainide
T23	Pharmacological_substance 600 610	Flecainide
N1011 	Reference T23 MeSH:D005424	Flecainide
T24	Disorder 646 665	atrial fibrillation
N6 	Reference T24 UMLS:C0004238	atrial fibrillation
T25	Pharmacological_substance 729 739	flecainide
N1012 	Reference T25 MeSH:D005424	flecainide
T27	Pharmacological_substance 843 853	flecainide
N1013 	Reference T27 MeSH:D005424	flecainide
T28	Pharmacological_substance 858 868	paroxetine
N1014 	Reference T28 MeSH:D017374	paroxetine
T29	Pharmacological_substance 943 953	Paroxetine
N1015 	Reference T29 MeSH:D017374	Paroxetine
T30	Pharmacological_substance 987 997	flecainide
N1016 	Reference T30 MeSH:D005424	flecainide
T32	Disorder 1036 1044	delirium
N7 	Reference T32 UMLS:C0011206	delirium
T33	Pharmacological_substance 1068 1078	Flecainide
N1017 	Reference T33 MeSH:D005424	Flecainide
T34	Disorder 1161 1169	delirium
N8 	Reference T34 UMLS:C0011206	delirium
T35	Pharmacological_substance 1302 1312	flecainide
N1018 	Reference T35 MeSH:D005424	flecainide
T38	Pharmacological_substance 1338 1348	paroxetine
N1019 	Reference T38 MeSH:D017374	paroxetine
T41	Pharmacological_substance 1399 1409	flecainide
N1020 	Reference T41 MeSH:D005424	flecainide
T42	Disorder 1418 1426	delirium
N9 	Reference T42 UMLS:C0011206	delirium
T43	Pharmacological_substance 1472 1482	flecainide
N1021 	Reference T43 MeSH:D005424	flecainide
T44	Disorder 1523 1531	delirium
N10 	Reference T44 UMLS:C0011206	delirium
T45	Pharmacological_substance 1639 1649	flecainide
N1022 	Reference T45 MeSH:D005424	flecainide
T46	Pharmacological_substance 1654 1664	paroxetine
N1023 	Reference T46 MeSH:D017374	paroxetine
T47	Pharmacological_substance 1683 1693	flecainide
N1024 	Reference T47 MeSH:D005424	flecainide
T48	Disorder 1726 1734	delirium
N11 	Reference T48 UMLS:C0011206	delirium
T49	Disorder 1744 1752	toxicity
N12 	Reference T49 UMLS:C0600688	toxicity
T50	Pharmacological_substance 1768 1778	flecainide
N1025 	Reference T50 MeSH:D005424	flecainide
T51	Pharmacological_substance 1798 1808	paroxetine
N1026 	Reference T51 MeSH:D017374	paroxetine
T54	Pharmacological_substance 1845 1855	flecainide
N1027 	Reference T54 MeSH:D005424	flecainide
T20	Subject 249 275	A 69-year-old white female
T22	Coreferring_mention 400 407	patient
T57	Speculation_cue 1151 1154	may
T60	Subject 1173 1193	susceptible patients
T64	Speculation_cue 1716 1719	may
T52	Speculation_cue 1589 1597	possible
T26	Combination 1793 1797	with
T37	Speculation_cue 1753 1756	may
T53	Speculation_cue 1491 1499	probable
